Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 12.9% | 10.4% | 4.2% | 50.2% | 11.0% | (23.3%) | (1.4%) | (3.5%) | (3.4%) | (4.8%) | 7.3% | (3.6%) | (1.9%) | (5.8%) | 0.8% | 9.1% | 3.6% | 13.8% | 17.2% | (4.5%) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 11.2%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Merck & Co., Inc. have been 8.5% over the past three years, and 10.1% over the past five years.
As of today, Merck & Co., Inc.'s ROIC - WACC is 11.2%, which is higher than industry median of 8.9%. It indicates that Merck & Co., Inc.'s ROIC - WACC is Good.